Crossref journal-article
Society for Neuroscience
The Journal of Neuroscience (393)
Abstract

In this study, we investigated the role of orexinergic systems in dopamine-related behaviors induced by the μ-opioid receptor agonist morphine in rodents. Extensive coexpression of tyrosine hydroxylase with orexin receptors was observed in the mouse ventral tegmental area (VTA). The levels of dopamine and its major metabolites in the nucleus accumbens were markedly increased by the microinjection of orexin A and orexin B into the VTA. The subcutaneous morphine-induced place preference and hyperlocomotion observed in wild-type mice were abolished in mice that lacked the prepro-orexin gene. An intra-VTA injection of a selective orexin receptor antagonist SB334867A [1-(2-methylbenzoxazol-6-yl)-3-[1.5]naphthyridin-4-yl urea] significantly suppressed the morphine-induced place preference in rats. Furthermore, the increased level of dialysate dopamine produced by morphine in the mouse brain was significantly decreased by deletion of the prepro-orexin gene. These findings provide new evidence that orexin-containing neurons in the VTA are directly implicated in the rewarding effect and hyperlocomotion induced by morphine through activation of the mesolimbic dopamine pathway in rodents.

Bibliography

Narita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., & Suzuki, T. (2006). Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine. The Journal of Neuroscience, 26(2), 398–405.

Authors 11
  1. Minoru Narita (first)
  2. Yasuyuki Nagumo (additional)
  3. Seiko Hashimoto (additional)
  4. Michiko Narita (additional)
  5. Junaidi Khotib (additional)
  6. Mayumi Miyatake (additional)
  7. Takeshi Sakurai (additional)
  8. Masashi Yanagisawa (additional)
  9. Tomoya Nakamachi (additional)
  10. Seiji Shioda (additional)
  11. Tsutomu Suzuki (additional)
References 40 Referenced 430
  1. 10.1016/0006-8993(91)90046-X
  2. 10.1016/S0304-3940(03)00829-2 / Neurosci Lett (2003)
  3. {'key': '2023041303161864000_26.2.398.3', 'first-page': '489', 'volume': '264', 'year': '1993', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther (1993)
  4. 10.1016/0149-7634(95)00033-B
  5. 10.1016/S0165-0173(98)00019-8
  6. 10.1016/S0304-3940(01)01826-2
  7. 10.1016/S0092-8674(00)81973-X
  8. 10.1210/en.143.8.2995
  9. 10.1073/pnas.96.2.748
  10. 10.1073/pnas.95.1.322
  11. 10.1002/cne.903450104
  12. 10.1016/S0306-4522(02)00017-9
  13. 10.1523/JNEUROSCI.23-08-03106.2003 / J Neurosci (2003)
  14. 10.1073/pnas.96.19.10911
  15. {'key': '2023041303161864000_26.2.398.15', 'first-page': '12', 'volume': '12', 'year': '1957', 'journal-title': 'Br J Pharmacol'} / Br J Pharmacol (1957)
  16. 10.1016/S0306-4522(01)00033-1
  17. 10.1016/0165-6147(92)90060-J
  18. 10.1523/JNEUROSCI.23-01-00007.2003 / J Neurosci (2003)
  19. {'key': '2023041303161864000_26.2.398.19', 'first-page': '2445', 'volume': '7', 'year': '1987', 'journal-title': 'J Neurosci'} / J Neurosci (1987)
  20. 10.1016/0006-8993(94)90031-0
  21. 10.1002/cne.1190
  22. {'key': '2023041303161864000_26.2.398.22', 'first-page': '617', 'volume': '3', 'year': '1984', 'journal-title': 'Neuroscience'} / Neuroscience (1984)
  23. 10.1016/S0006-8993(00)02555-5
  24. 10.1007/BF02253531
  25. 10.1016/S0163-7258(00)00099-1
  26. 10.1074/jbc.M009716200
  27. 10.1016/S0306-4522(01)00515-2
  28. 10.1016/S0006-8993(03)02301-1 / Brain Res (2003)
  29. Paxinos G, Franklin KBJ (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic.
  30. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. New York: Academic.
  31. 10.1523/JNEUROSCI.18-23-09996.1998 / J Neurosci (1998)
  32. 10.1016/0024-3205(83)90159-5
  33. 10.1016/S0092-8674(00)80949-6
  34. 10.1016/0014-2999(88)90803-5
  35. {'key': '2023041303161864000_26.2.398.35', 'first-page': '53', 'volume': '265', 'year': '1993', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther (1993)
  36. 10.1007/BF02247122 / Psychopharmacology (1990)
  37. 10.1097/00001756-200107030-00024
  38. 10.1523/JNEUROSCI.19-08-03171.1999 / J Neurosci (1999)
  39. 10.1523/JNEUROSCI.15-07-05169.1995 / J Neurosci (1995)
  40. 10.1146/annurev.ps.40.020189.001203
Dates
Type When
Created 19 years, 7 months ago (Jan. 11, 2006, 5:20 p.m.)
Deposited 2 years, 4 months ago (April 13, 2023, 1:09 p.m.)
Indexed 58 minutes ago (Sept. 4, 2025, 2:49 a.m.)
Issued 19 years, 7 months ago (Jan. 11, 2006)
Published 19 years, 7 months ago (Jan. 11, 2006)
Published Online 19 years, 7 months ago (Jan. 11, 2006)
Published Print 19 years, 7 months ago (Jan. 11, 2006)
Funders 0

None

@article{Narita_2006, title={Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine}, volume={26}, ISSN={1529-2401}, url={http://dx.doi.org/10.1523/jneurosci.2761-05.2006}, DOI={10.1523/jneurosci.2761-05.2006}, number={2}, journal={The Journal of Neuroscience}, publisher={Society for Neuroscience}, author={Narita, Minoru and Nagumo, Yasuyuki and Hashimoto, Seiko and Narita, Michiko and Khotib, Junaidi and Miyatake, Mayumi and Sakurai, Takeshi and Yanagisawa, Masashi and Nakamachi, Tomoya and Shioda, Seiji and Suzuki, Tsutomu}, year={2006}, month=jan, pages={398–405} }